Valérie Ugo

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature · 2005 · 3.5K citations

Hematological Malignancy, Signal Transduction, Receptor Tyrosine Kinase +9

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Nicole Casadevall, J Nataf, B Viron et al. · New England Journal of Medicine · 2002 · 1.2K citations

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

Sabrina Dupont, Aline Massé, Chloé James et al. · Blood · 2007 · 184 citations

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients

Xénia Cabagnols, Fabrizia Favale, Florence Pasquier et al. · Blood · 2015 · 182 citations · Full text

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera

Valérie Ugo, Christophe Marzac, Irène Teyssandier et al. · Experimental Hematology · 2004 · 165 citations · Full text

Multiple Signaling Pathways, Polycythemia Vera, Developmental Biology +9